Patents by Inventor Olivier Gaide

Olivier Gaide has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF ECTODERMAL DYSPLASIA
    Publication number: 20160272694
    Abstract: The invention relates to pharmaceutical compositions and methods for the treatment of ectodermal displasias via the administration of EDA agonists, in particular EDI200. Use of the compositions and methods described allow for therapeutic dosing and administration regimens in human patients to correct or alter abnormal phenotypes associated with genetic disorders, in particular, XLHED.
    Type: Application
    Filed: November 13, 2013
    Publication date: September 22, 2016
    Inventors: Kenneth M. Huttner, Neil Kirby, Jr., Pascal Schneider, Olivier Gaide
  • FUSION CONSTRUCTS CONTAINING ACTIVE SECTIONS OF TNF LIGANDS
    Publication number: 20150098944
    Abstract: Disclosed is a recombinant fusion protein containing an amino-acid sequence which comprises: (a) the Fc section or part of an Fc section of an immunoglobulin as component (A) or a functional variant of component (A); (b) the extracellular part of a TNF ligand or a partial sequence of the extracellular part of a TNF ligand as component (B) or a functional variant of component (B); and optionally (c) a transition area between component (A) and component (B), containing a linker.
    Type: Application
    Filed: October 23, 2014
    Publication date: April 9, 2015
    Inventors: Olivier Gaide, Pascal Schneider, Jurg Tschopp
  • Pharmaceutical composition comprising EDA-1 Fusion Protein
    Patent number: 8895003
    Abstract: Disclosed is a recombinant fusion protein containing an amino-acid sequence which comprises: (a) the Fc section or part of an Fc section of an immunoglobulin as component (A) or a functional variant of component (A); (b) the extracellular part of a TNF ligand or a partial sequence of the extracellular part of a TNF ligand as component (B) or a functional variant of component (B); and optionally (c) a transition area between component (A) and component (B), containing a linker.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: November 25, 2014
    Assignee: Topotarget Switzerland SA
    Inventors: Olivier Gaide, Pascal Schneider, Jurg Tschopp
  • FUSION CONSTRUCTS CONTAINING ACTIVE SECTIONS OF TNF LIGANDS
    Publication number: 20130295093
    Abstract: Disclosed is a recombinant fusion protein containing an amino-acid sequence which comprises: (a) the Fc section or part of an Fc section of an immunoglobulin as component (A) or a functional variant of component (A); (b) the extracellular part of a TNF ligand or a partial sequence of the extracellular part of a TNF ligand as component (B) or a functional variant of component (B); and optionally (c) a transition area between component (A) and component (B), containing a linker.
    Type: Application
    Filed: June 20, 2013
    Publication date: November 7, 2013
    Inventors: Olivier GAIDE, Pascal SCHNEIDER, Jurg Tschopp
  • Treatment of ectodermal dysplasia with EDA1 fusion proteins
    Patent number: 8501177
    Abstract: Disclosed is a recombinant fusion protein containing an amino-acid sequence which comprises: (a) the Fc section or part of an Fc section of an immunoglobulin as component (A) or a functional variant of component (A); (b) the extracellular part of a TNF ligand or a partial sequence of the extracellular part of a TNF ligand as component (B) or a functional variant of component (B); and optionally (c) a transition area between component (A) and component (B), containing a linker.
    Type: Grant
    Filed: April 8, 2010
    Date of Patent: August 6, 2013
    Assignee: Topotarget Switzerland SA
    Inventors: Olivier Gaide, Pascal Schneider, Jurg Tschopp
  • FUSION CONSTRUCTS CONTAINING ACTIVE SECTIONS OF TNF LIGANDS
    Publication number: 20100254984
    Abstract: Disclosed is a recombinant fusion protein containing an amino-acid sequence which comprises: (a) the Fc section or part of an Fc section of an immunoglobulin as component (A) or a functional variant of component (A); (b) the extracellular part of a TNF ligand or a partial sequence of the extracellular part of a TNF ligand as component (B) or a functional variant of component (B); and optionally (c) a transition area between component (A) and component (B), containing a linker.
    Type: Application
    Filed: April 8, 2010
    Publication date: October 7, 2010
    Applicant: APOXIS S.A.
    Inventors: Olivier Gaide, Pascal Schneider, Jurg Tschopp
  • Fusion constructs containing active sections on TNF ligands
    Patent number: 7736657
    Abstract: Disclosed is a recombinant fusion protein containing an amino-acid sequence which comprises: (a) the Fc section or part of an Fc section of an immunoglobulin as component (A) or a functional variant of component (A); (b) the extracellular part of a TNF ligand or a partial sequence of the extracellular part of a TNF ligand as component (B) or a functional variant of component (B); and optionally (c) a transition area between component (A) and component (B), containing a linker.
    Type: Grant
    Filed: August 21, 2002
    Date of Patent: June 15, 2010
    Assignee: Apoxis S.A.
    Inventors: Olivier Gaide, Pascal Schneider, Jürg Tschopp
  • Fusion constructs cotaining active sections of tnf ligands
    Publication number: 20050152872
    Abstract: Disclosed is a recombinant fusion protein containing an amino-acid sequence which comprises: (a) the Fc section or part of an Fc section of an immunoglobulin as component (A) or a functional variant of component (A); (b) the extracellular part of a TNF ligand or a partial sequence of the extracellular part of a TNF ligand as component (B) or a functional variant of component (B); and optionally (c) a transition area between component (A) and component (B), containing a linker.
    Type: Application
    Filed: August 21, 2002
    Publication date: July 14, 2005
    Inventors: Olivier Gaide, Pascal Schneider, Jurg Tschopp